Total Payments
$15,691
2024 Payments
$2,606
Companies
46
Transactions
881
Medicare Patients
4,924
Medicare Billing
$573,081
Payment Breakdown by Category
Food & Beverage$15,603 (99.4%)
Education$88.30 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,603 | 871 | 99.4% |
| Education | $88.30 | 10 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $3,931 | 253 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,794 | 101 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,612 | 84 | $0 (2024) |
| Grifols USA, LLC | $1,197 | 69 | $0 (2024) |
| Amgen Inc. | $631.84 | 34 | $0 (2024) |
| Mylan Specialty L.P. | $628.92 | 42 | $0 (2024) |
| United Therapeutics Corporation | $460.07 | 19 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $458.61 | 21 | $0 (2018) |
| Baxter Healthcare | $456.29 | 24 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $444.67 | 28 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,606 | 129 | GlaxoSmithKline, LLC. ($554.08) |
| 2023 | $2,650 | 148 | GlaxoSmithKline, LLC. ($807.35) |
| 2022 | $2,624 | 142 | GlaxoSmithKline, LLC. ($632.71) |
| 2021 | $1,922 | 108 | GlaxoSmithKline, LLC. ($422.37) |
| 2020 | $1,229 | 77 | GlaxoSmithKline, LLC. ($415.39) |
| 2019 | $1,238 | 79 | GlaxoSmithKline, LLC. ($339.15) |
| 2018 | $1,304 | 82 | GlaxoSmithKline, LLC. ($312.12) |
| 2017 | $2,117 | 116 | GlaxoSmithKline, LLC. ($448.08) |
All Payment Transactions
881 individual payment records from CMS Open Payments — Page 1 of 36
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: Pulmonology | ||||||
| 12/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: RESPIRATORY | ||||||
| 12/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Immunology | ||||||
| 12/09/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: RESPIRATORY | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: Respiratory | ||||||
| 11/22/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/20/2024 | Baxter Healthcare | Hillrom - Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: Airway Clearance Device | ||||||
| 11/20/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/19/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: Pulmonology | ||||||
| 11/18/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $9.35 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $27.70 | General |
| 11/11/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: RESPIRATORY | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: Respiratory | ||||||
| 11/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: RESPIRATORY | ||||||
| 10/31/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.77 | General |
| Category: Immunology | ||||||
| 10/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $27.93 | General |
| 10/28/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: RESPIRATORY | ||||||
| 10/24/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.17 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/22/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: Cardiology | ||||||
| 10/21/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $32.58 | General |
| Category: NEUROLOGY | ||||||
| 10/15/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Pulmonology | ||||||
| 10/08/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: Immunology | ||||||
| 10/08/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,304 | 2,234 | $404,977 | $150,685 |
| 2022 | 15 | 1,166 | 1,813 | $329,642 | $108,218 |
| 2021 | 14 | 1,108 | 1,887 | $385,427 | $140,278 |
| 2020 | 19 | 1,346 | 2,288 | $470,925 | $173,900 |
Total Patients
4,924
Total Services
8,222
Medicare Billing
$573,081
Procedure Codes
65
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 180 | 558 | $91,587 | $49,946 | 54.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 105 | 242 | $123,420 | $39,263 | 31.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 115 | 442 | $50,830 | $26,599 | 52.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 112 | 145 | $24,940 | $9,415 | 37.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 125 | 129 | $14,319 | $5,297 | 37.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 47 | 51 | $20,655 | $4,876 | 23.6% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 36 | 37 | $21,645 | $3,406 | 15.7% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 29 | 29 | $15,718 | $2,622 | 16.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 28 | 28 | $7,980 | $2,569 | 32.2% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2023 | 132 | 134 | $5,226 | $1,142 | 21.9% |
| 71271 | Low dose ct scan of chest for lung cancer screening | Office | 2023 | 13 | 13 | $4,225 | $1,123 | 26.6% |
| 71250 | Ct scan of chest without contrast | Office | 2023 | 13 | 16 | $5,376 | $1,049 | 19.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 19 | 19 | $3,838 | $946.05 | 24.6% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 136 | 138 | $3,864 | $874.86 | 22.6% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 114 | 117 | $3,042 | $656.76 | 21.6% |
| 71045 | X-ray of chest, 1 view | Facility | 2023 | 60 | 96 | $6,432 | $587.25 | 9.1% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 40 | 40 | $1,880 | $312.80 | 16.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 94 | 195 | $99,450 | $31,327 | 31.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 116 | 341 | $55,924 | $25,932 | 46.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 99 | 342 | $39,330 | $18,063 | 45.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 121 | 149 | $25,628 | $9,278 | 36.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 113 | 132 | $14,652 | $6,695 | 45.7% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2022 | 41 | 41 | $23,985 | $3,740 | 15.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 32 | 32 | $9,120 | $3,140 | 34.4% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2022 | 29 | 29 | $15,718 | $2,687 | 17.1% |
About Dr. Marque Hunter, M.D
Dr. Marque Hunter, M.D is a Pulmonary Disease healthcare provider based in Lubbock, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1568485258.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marque Hunter, M.D has received a total of $15,691 in payments from pharmaceutical and medical device companies, with $2,606 received in 2024. These payments were reported across 881 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($15,603).
As a Medicare-enrolled provider, Hunter has provided services to 4,924 Medicare beneficiaries, totaling 8,222 services with total Medicare billing of $573,081. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Lubbock, TX
- Active Since 07/25/2006
- Last Updated 10/20/2009
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1568485258
Products in Payments
- TRELEGY ELLIPTA (Drug) $1,896
- Prolastin-C Liquid (Biological) $986.77
- DUPIXENT (Biological) $809.64
- OFEV (Drug) $738.04
- TEZSPIRE (Biological) $721.19
- NUCALA (Biological) $708.75
- ANORO (Drug) $486.32
- XARELTO (Drug) $406.87
- GLASSIA (Biological) $375.36
- STIOLTO RESPIMAT (Drug) $353.49
- Hillrom - Life 2000 Ventilation System (Device) $315.27
- Esbriet (Biological) $313.58
- ORENITRAM (Drug) $312.27
- FASENRA (Biological) $305.07
- Yupelri (Drug) $302.36
- BREO (Drug) $291.73
- ANORO ELLIPTA (Drug) $285.20
- YUPELRI (Drug) $279.17
- AREXVY (Drug) $263.61
- OPSUMIT (Drug) $243.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Lubbock
Shannon Turnbow, Md, MD
Pulmonary Disease — Payments: $22,266
Pulmonary Disease $22,266
Brian Williams, Md, MD
Pulmonary Disease — Payments: $16,308
Pulmonary Disease $16,308
Dr. Victor Test, M.d, M.D
Pulmonary Disease — Payments: $16,202
Pulmonary Disease $16,202
Mark Johnson, Md, MD
Pulmonary Disease — Payments: $10,815
Pulmonary Disease $10,815
Srinivas Kadiyala, Md, MD
Pulmonary Disease — Payments: $9,235
Pulmonary Disease $9,235
Naidu Chekuru, Md, MD
Pulmonary Disease — Payments: $9,042
Pulmonary Disease $9,042